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Development and Characterization of Human Tumor Models by
Orthotopic Implantation
In this study the following human tumor xenografts were implanted
orthotopically in nude mice: colon carcinoma CXF 1103T, bladder
carcinoma BXF 1299T, prostate carcinomas PRXF PC3T, PC3MT,
PC3MMT and the ascites model PRXF PC3MAS. In case of four models
implanted tumor material derived from xenografts growing subcutaneously
in nude mice. For implantation of PRXF PC3MT and PRXF PC3MAS
orthotopically growing xenografts were used as donor material.
With the exception of PRXF PC3(T), take rates of orthotopic and ectopic
models were similar. However, xenografts implanted into the orthotopic site
grew faster than the xenografts at the heterotopic site.
These results confirm with the examinations of other groups. Low take rate
of PRXF PC3T could not be explained by going through literature.
The fact that human tumor cells only metastasize when implanted in the
corresponding organ was beared out in the present study. Median
metastasis rate amounted to 74 %. Distribution of secondary lesions was
almost similar to the situation in the corresponding patient. Correspondance
as well as divergence from the patient tumor has been described but not
explained before. Data presented in this study allow to suppose a correlation
between the metastastic behavior of the tumor in the mouse and the
different influences on the resected patient specimen before implantation.
Histologically, primary tumor and metastatic lesions were similar when
human tumors were implanted in the corresponding organ of the nude
mouse. The histology was not influenced by the transplantation site. Even
the specimen obtained from the patient had histologically high similarities
with the xenograft growing in nude mice. Thus, histological structure was not
influenced by the tumor environment or host biology.
The expression of human cytokeratin was determined by
immunohistochemistry. Since the expression was independent of
localization of the tumor, measurement of cytokeratin was a feasible method
to detect micrometastases. For colon carcinoma CXF 1103T the expression
of carcinoembryogenic antigen (CEA) was determined. This xenograft did
express the tumor marker irrespective of the implantation site. In patient
serum however CEA-levels were not detectable. Originally, CXF 1103T was




The results of histological and immunohistological examinations correlated
well with the results of other groups.
Cytological examination of the ascites model showed no relation between
tumor cell concentration or relative tumor cell number found in the pleural
and peritoneal cavity on one hand and the number of injected tumor cells or
their origin on the other hand.
The influence of the implantation site on structural quality of tumor vessels
was discussed contrarily. Vascular permeability was not influenced by the
implantation site. Apart from visceral metastases, these tumors retained
much more dye than the primary tumors. Thus, the selective process of
metastasis enhanced  porosity of the tumor vessels.
For BXF 1299T and PRXF PC3MT chemosensitivity against standard
anticancer agents was tested. Orthotopic implanted tumors turned out to be
a feasible model for anticancer drug testing in vivo. In contrast to
observations of other authors, chemosensitivity was not influenced by the
localization of the tumor. The orthotopic models showed a slightly enhanced
responsivness in comparison to their subcutaneous counterpart. This
phenomenon could be explained by the fact that the chemosensitivity profile
of the selected xenografts showed even in the subcutaneous model high
correspondence with the patient tumor.
Thus, testing anticancer drugs in the subcutaneous model before turning to
the large-scale orthotopic model seamed to be a appropriate strategy.
So far as the tested anticancer drugs showed antitumoral activity they also
inhibited the development of metastases. Therefore, the examinated
orthotopic models turned out to be suitable for development of
antimetastatic drugs.
This study illuminated the importance of human orthotopic models in
oncology. Developing antimetastastic drugs as well as testing of local
therapies seem to be the most important application for the models
described in this thesis. In addition, they allow to study different aspects of
tumor biology and will facilitate the development of new anticancer
strategies.
